Conference Quick Report | Chengtian Biotechnology Shares Innovative Practices in Clinical Sample Import at the 2024 DIA Annual Conference

On May 17, 2024, the 16th International Drug Information Conference and 2024 DIA Annual Conference and Exhibition were grandly held in Suzhou, China. This grand event brings together leading figures in the global pharmaceutical and health field to discuss the future trends of the pharmaceutical industry, the application of innovative technologies, and the importance of international cooperation, providing attendees with profound industry insights and rich opportunities for communication.

As a leading enterprise in the field of cross-border biopharmaceutical services, Chengtian Biotechnology was invited to participate in a special seminar on "Biological Sample Export and Data Export" and shared practical cases and experiences in the compliance cross-border field as a guest company. The keynote speaker for this session is Ms. Feng Xing, Senior Manager of Cross border Supply Chain Compliance. She delivered a keynote speech on "The First National Clinical Sample Import and Cross border Joint Risk Assessment".

Ms. Feng shared a practical case of national policy innovation she experienced, namely the "Customs Local Collaboration" innovation policy that was piloted in Chengdu and further promoted to the three customs districts of Shanghai, Nanjing, and Chengdu, as well as cross customs collaboration among local government departments. This policy successfully ensured the smooth implementation of a global clinical project (importing human serum, human plasma, and tissue slices into China), jointly safeguarding the projects participated by enterprises from the three regions. On the basis of adhering to the bottom line of biosafety, we aim to assist Chinese research and development enterprises in better participating in international projects.

Ms. Feng's sharing received widespread attention and praise from the attendees, providing valuable reference and inspiration for the cross-border service industry. Chengtian Biotechnology is committed to promoting the healthy development of the biopharmaceutical industry and cross-border biopharmaceutical products through continuous innovation and cooperation.

We look forward to working hand in hand with all our partners to explore a broader market space and create a better future together! On behalf of all employees of Chengtian Biotechnology, we would like to express our sincere gratitude to the organizers and all participants of this conference, and wish our cooperation to become closer and more successful!

iBL Products Cross border,

Welcome to inquire!